Epicardial Mitral Repair Trial - ENRAPT-MR

Inclusion Criteria: * Patient has moderate (2+), moderate-to-severe (3+) or severe (4+) ischemic or functional Mitral regurgitation per 2D or 3D echocardiography, symptomatic or asymptomatic * Patient is 18 years of age or older * Patient is willing and able to sign informed consent form Exclusion Criteria: * History of endocarditis or current endocarditis * Structural abnormalities of the leaflets and papillary muscles\* * Dysfunctional chordae\* * Any prior cardiac surgery including but not limited to CABG, Mitral Valve repair surgery, mechanical prosthetic Valve, or ventricular assist device, prior sternotomy\* * Ejection fraction \<25% * New York Hheart Association (NYHA) class IV * MV diameters \> 7cm * Myxomatous Mitral regurgitation * Renal insufficiency (eGFR \&lt; 30 ml/min) * Severely calcified (posterior) Mitral Valve annulus * Women who are pregnant (by history of menstrual period or pregnancy test if history is considered unreliable) * Any coronary artery calcification at site of placement as determined by angiogram. * Abnormal cardiac anatomy discovered prior to surgery or during procedure. * Pericardial adhesions * NOTE: Patients with prior or concurrent mitral chordae repair (example: PTFE or Neochord) are potential candidates for the MitralTouch